For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The closing price of Immunome Inc (NASDAQ: IMNM) was $8.19 for the day, up 2.37% from the previous closing price of $8.00. In other words, the price has increased by $2.37 from its previous closing price. On the day, 0.79 million shares were traded. IMNM stock price reached its highest trading level at $8.36 during the session, while it also had its lowest trading level at $7.9209.
Ratios:
Our analysis of IMNM’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.08 and its Current Ratio is at 4.08. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Lake Street on April 02, 2025, initiated with a Buy rating and assigned the stock a target price of $23.
On November 08, 2024, Stephens started tracking the stock assigning a Overweight rating and target price of $30.
On May 31, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $27.Piper Sandler initiated its Overweight rating on May 31, 2024, with a $27 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 25 ’25 when BIENAIME JEAN JACQUES bought 7,800 shares for $7.78 per share. The transaction valued at 60,684 led to the insider holds 31,415 shares of the business.
SIEGALL CLAY B bought 137,100 shares of IMNM for $999,459 on Mar 26 ’25. The President and CEO now owns 806,736 shares after completing the transaction at $7.29 per share. On Mar 24 ’25, another insider, BIENAIME JEAN JACQUES, who serves as the Director of the company, bought 7,000 shares for $8.21 each. As a result, the insider paid 57,470 and bolstered with 23,615 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMNM now has a Market Capitalization of 712126208 and an Enterprise Value of 499654880. For the stock, the TTM Price-to-Sale (P/S) ratio is 78.78 while its Price-to-Book (P/B) ratio in mrq is 2.91. Its current Enterprise Value per Revenue stands at 55.265 whereas that against EBITDA is -3.29.
Stock Price History:
The Beta on a monthly basis for IMNM is 1.82, which has changed by -0.42606866 over the last 52 weeks, in comparison to a change of 0.042615533 over the same period for the S&P500. Over the past 52 weeks, IMNM has reached a high of $16.81, while it has fallen to a 52-week low of $5.15. The 50-Day Moving Average of the stock is -1.91%, while the 200-Day Moving Average is calculated to be -29.53%.
Shares Statistics:
IMNM traded an average of 1.18M shares per day over the past three months and 1256190 shares per day over the past ten days. A total of 86.95M shares are outstanding, with a floating share count of 75.42M. Insiders hold about 13.27% of the company’s shares, while institutions hold 61.52% stake in the company. Shares short for IMNM as of 1743379200 were 11132992 with a Short Ratio of 9.46, compared to 1740700800 on 9302077. Therefore, it implies a Short% of Shares Outstanding of 11132992 and a Short% of Float of 13.309999999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
